5472 Federal Register / Vol. 81, No. 21 / Tuesday, February 2, 2016 / Notices 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued 

Activity Number of 

respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average 

burden per 

response 

Total hours 

Total Youth Hours .............................................. ........................ ........................ ........................ .................................. 380 

Total Hours .................................................. ........................ ........................ ........................ .................................. 1,899 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

FDA’s burden estimate is based on 

prior experience with research that is 

similar to this proposed study. 

Approximately 30,000 respondents will 

complete a screener to determine 

eligibility for participation in a study, 

estimated to take approximately 2 

minutes (0.03 hours), for a total of 900 

hours for screening activities. Three 

thousand respondents will complete a 

full study, estimated to last 20 minutes 

(0.333 hours), for a total of 999 hours for 

completion of both adult studies and 1 

youth study. The estimated total hour 

burden of the collection of information 

is 1,899 hours. 

References 

The following references are on 

display in the Division of Dockets 

Management (see ADDRESSES) and are 

available for viewing by interested 

persons between 9 a.m. and 4 p.m., 

Monday through Friday; they are also 

available electronically at http://

www.regulations.gov. 

1. Keller, Kevin L. and Donald R. Lehman, 

‘‘Brands and Branding: Research 

Findings and Future Priorities,’’ 

Marketing Science, vol. 25, no. 6, pp. 

740–759, 2006. 

2. Eagly, Alice H. and Shelly Chaiken, 

‘‘Process Theories of Attitude Formation 

and Change: Reception and Cognitive 

Responding,’’ The Psychology of 

Attitudes, Chapter 6, Harcourt Brace 

Jovanovich College Publishers, 1993. 

Dated: January 27, 2016. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2016–01788 Filed 2–1–16; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Medical Imaging Investigations. 

Date: February 18, 2016. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Mehrdad Mohseni, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5211, 

MSC 7854, Bethesda, MD 20892, 301–435– 

0484; mohsenim@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group, Diseases and Pathophysiology of the 

Visual System Study Section. 

Date: February 25–26, 2016. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 West 

Mission Bay Drive, San Diego, CA 92109. 

Contact Person: Nataliya Gordiyenko, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5202, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1265; gordiyenkon@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group, Cancer Immunopathology and 

Immunotherapy Study Section. 

Date: February 25–26, 2016. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Dupont Hotel, 1500 New 

Hampshire Avenue NW., Washington, DC 

20036. 

Contact Person: Denise R Shaw, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6158, 

MSC 7804, Bethesda, MD 20892, 301–435– 

0198; shawdeni@csr.nih.gov. 

Name of Committee: Oncology 1—Basic 

Translational Integrated Review Group, 

Tumor Progression and Metastasis Study 

Section. 

Date: March 2–3, 2016. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Rolf Jakobi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6187, 

MSC 7806, Bethesda, MD 20892, 301–495– 

1718; jakobir@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Alcohol, Drugs and 

Neurotoxicology. 

Date: March 2–3, 2016. 

Time: 8:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Michael Selmanoff, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5164, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1119; selmanom@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR–13– 

327: Innovative Molecular Analysis 

Technology Development for Cancer 

Research and Clinical Care. 

Date: March 2, 2016. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Zhang-Zhi Hu, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6186, 

MSC 7804, Bethesda, MD 20892, (301) 594– 

2414; huzhuang@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine, 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846– 93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 27, 2016. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–01818 Filed 2–1–16; 8:45 am] 

BILLING CODE 4140–01–P 


wgreen on DSK2VPTVN1PROD with NOTICES